Sun Pharma posts 2 percent fall in Q1 profit Ruchika Sharma4 Aug 2023 10:30 AM ISTGlobal specialty sales, which accounted for 16.2 percent of total sales during the quarter, rose 21 percent percent in the quarter, the company said.
Sun Pharma eyes high single-digit revenue growth in FY24 Ruchika Sharma31 July 2023 1:30 PM ISTThe drug maker is currently sitting on a net cash position of around USD 1.5 billion, Shanghvi said.
Alembic Pharma, Sun Pharma recall drugs in US over manufacturing issues Ruchika Sharma31 July 2023 12:30 PM ISTThe US Health regulator stated that Alembic Pharmaceuticals is recalling 2,844 units of Diclofenac Sodium Topical Solution in the American market.
Ensure safety, efficacy of applied Synthetic product: CDSCO panel Tells Sun Pharma for Liraglutide Injection Dr. Divya Colin27 July 2023 6:00 PM ISTNew Delhi: Rejecting the request presented by drug major Sun Pharma for a clinical trial waiver for glucagon-like peptide-1 analog Liraglutide...
Sun Pharma gets CDSCO Panel nod to study Lumateperone Capsules Dr. Divya Colin29 Jun 2023 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under Central Drug Standard Control Organization (CDSCO) has granted permission to drug major...
Sun Pharma Gets CDSCO Panel Nod to Manufacture, Market Gabapentin for neuropathic pain Dr. Divya Colin27 Jun 2023 6:00 PM ISTNew Delhi: Pharmaceutical major Sun Pharma has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Sun Pharma gets Health Canada nod for acne cream Winlevi Ruchika Sharma20 Jun 2023 1:30 PM ISTWINLEVI targets the androgen receptor in the skin to tackle sebum production and inflammation.
Sun Pharma gets Chinese nod for plaque psoriasis injection Tildrakizumab Ruchika Sharma31 May 2023 11:29 AM ISTILUMETRI is a humanized, anti-IL-23p19 monoclonal antibody designed to selectively block the cytokine IL-23.
Sun Pharma, Philogen collaborate to commercialise anti-cancer biopharmaceutical Nidlegy in Europe, Australia and New Zealand Ruchika Sharma30 May 2023 12:34 PM ISTThe two partner companies will share post-commercialization economics in about 50:50 ratio.
Sun Pharma appoints new Whole-time Director, Independent Director Ruchika Sharma29 May 2023 3:33 PM ISTMumbai: Sun Pharma has recently announced that the Company's Board has approved the appointment of Aalok Shanghvi as a Whole-time Director and...
Sun Pharma proposes to fully acquire Taro Pharmaceutical Industries Ruchika Sharma29 May 2023 12:30 PM ISTUnder the indicative proposal, post the acquisition, Taro will become a wholly-owned subsidiary of Sun Pharma and will be delisted from NYSE.
Sun Pharma reports consolidated net profit of Rs 1984 crore in Q4 Ruchika Sharma27 May 2023 1:30 PM IST"Several of our businesses, including specialty, India and emerging markets have continued to progress well," Sun Pharma Managing Director Dilip...
